Osteoporosis affects both men and women, but women face higher risks due to biological differences, menopause, and pregnancy.

Background. Increased risk of osteoporosis and its clinical significance in patients with diabetes is controversial. We analyze osteoporosis prevalence and determinants of bone mineral density ...

Osteoporosis, characterized by an imbalance in bone remodeling, is a growing health concern worldwide. Previous research has ...

Osteoporosis, characterized by an imbalance in bone remodeling, is a growing health concern worldwide. Previous research has ...

Clinical practice guidelines (CPGs) are essential for guiding rehabilitation interventions. However, CPGs specifically addressing rehabilitation for osteoporosis patients remain scarce in the ...

But while the pair are used to competing at the highest level despite their disabilities, for Debra Sales-Tiffin, from Essex, ...

Osteoporosis, often described as a "silent disease," is characterized by weakened and brittle bones that become increasingly prone to fractures. This condition ...

Dear H.W.: Raloxifene was approved for use in 1997 in the United States as prevention for osteoporosis, and in 2007, it was ...

Denosumab biosimilar is under clinical development by Samsung Bioepis and currently in Phase III for Post Menopausal Osteoporosis.

According to the latest data from the Royal Osteoporosis Society, over 19,000 fractures are expected during the two-week ...

Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov. 5, 2024 — Researchers employed analysis tools and machine learning algorithms to identify two genes linked to ...

Researchers explored the association between osteoporosis and patient-reported outcomes among postmenopausal women with systemic sclerosis.